Mankind Pharma Outperforms Sector Amid Broader Market Gains and Mixed Performance Metrics

Mankind Pharma has shown significant activity today, with the stock rising by 3.19% on April 16, 2025. This performance has allowed it to outperform its sector by 3.44%. Over the past three days, Mankind Pharma has experienced a consecutive gain, accumulating a total return of 7.74% during this period. The stock reached an intraday high of Rs 2511.95, marking a 3.46% increase.
In terms of moving averages, Mankind Pharma's stock is currently above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains below the 100-day moving average.

In the broader market context, the Sensex opened higher at 76,996.78, gaining 261.89 points (0.34%), and is currently trading at 76,758.81, reflecting a slight increase of 0.03%. The BSE Small Cap index is leading the market today, with a gain of 0.93%.

Mankind Pharma's performance metrics over various time frames indicate a year-to-date decline of 12.77%, contrasting with the Sensex's decline of 1.74%. Over the past year, Mankind Pharma has achieved a return of 9.96%, compared to the Sensex's 5.26%.